Definitive Healthcare Welcomes New SVP with Inducement Awards

Definitive Healthcare Unveils Inducement Grants
Definitive Healthcare Corporation, recognized as a leader in healthcare commercial intelligence, has made an announcement regarding the induction of a senior leader into its ranks. The company is excited to share that Jeff Moyer has joined as the Senior Vice President of Growth and Sales Operations.
Inducement Awards Granted to Jeff Moyer
As part of his hiring, the Human Capital Management and Compensation Committee of Definitive Healthcare's Board of Directors has granted him inducement awards. Specifically, he has received 364,432 time-based restricted stock units (RSUs), which were allocated to him effective April 3. These inducement awards were negotiated individually to provide a material incentive for Mr. Moyer's commencement of employment.
Terms and Vesting Schedules of RSUs
The RSUs awarded to Mr. Moyer are governed by the terms outlined in Definitive Healthcare’s 2023 Inducement Plan. They come with specific conditions regarding their vesting, which is contingent on Mr. Moyer's continued employment. The structure allows for 25% of the awarded RSUs to vest on April 1, 2026. Following this initial vesting, the remainder will become vested in quarterly increments of 6.25% until fully vested over three years.
Overview of Definitive Healthcare
Definitive Healthcare is dedicated to transforming data into valuable healthcare commercial intelligence. By leveraging analytics and insights, the company aids its customers in identifying profitable markets and opportunities. Their SaaS platform is designed to navigate the complex healthcare industry, allowing companies to strategize effectively for future success.
Investor and Media Contacts
For further inquiries, Brian Denyeau from ICR is the investor contact, reachable at 646-277-1251 or via email at brian.denyeau@icrinc.com. For media-related questions, Bethany Swackhamer can be contacted at bswackhamer@definitivehc.com.
Frequently Asked Questions
What are inducement awards?
Inducement awards are stock options or other securities granted to new employees as an incentive for them to join the company.
What is the role of an SVP of Growth and Sales Operations?
The SVP of Growth and Sales Operations focuses on driving revenue growth and overseeing sales strategies within an organization.
How does the RSU vesting schedule work?
The RSU vesting schedule specifies the timeline over which the granted units become fully owned by the recipient, typically requiring continued employment.
What is Definitive Healthcare's primary focus?
Definitive Healthcare primarily focuses on transforming data and analytics into actionable intelligence within the healthcare sector.
Who should potential investors contact for more information?
Potential investors can contact Brian Denyeau for more information about the company's investments and performance.
About The Author
Contact Lucas Young privately here. Or send an email with ATTN: Lucas Young as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.